Table 1.
Survival |
NT |
Eye |
DT |
2 wk/4 wk DT |
2 wk/6 wk DT |
1 wk | 6 | 6 | 6 | NM | NM |
2 wk | 6 | 7 | 6 | NM | NM |
4 wk | 1 | 4 | 7 | 3 | NM |
6 wk | NM | NM | NM | NM | 4 |
The 1- and 2-week data are from the study of Weber et al.15 NM, not measured; DT, dual treatment; 2 wk/4 wk, 2-week treatment/4-week postcrush survival; 2 wk/6 wk, 2-week treatment/6-week postcrush survival.